WO2014085946A1 - Grass- and shrub-based natural antioxidant liquid composition and method for producing same - Google Patents
Grass- and shrub-based natural antioxidant liquid composition and method for producing same Download PDFInfo
- Publication number
- WO2014085946A1 WO2014085946A1 PCT/CL2013/000002 CL2013000002W WO2014085946A1 WO 2014085946 A1 WO2014085946 A1 WO 2014085946A1 CL 2013000002 W CL2013000002 W CL 2013000002W WO 2014085946 A1 WO2014085946 A1 WO 2014085946A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- concentrated
- liquid composition
- herbs
- natural antioxidant
- shrubs
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 37
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 32
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 31
- 239000007788 liquid Substances 0.000 title claims abstract description 18
- 238000004519 manufacturing process Methods 0.000 title abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 244000228451 Stevia rebaudiana Species 0.000 claims abstract description 6
- 235000009499 Vanilla fragrans Nutrition 0.000 claims abstract description 6
- 235000010676 Ocimum basilicum Nutrition 0.000 claims abstract description 5
- 240000007926 Ocimum gratissimum Species 0.000 claims abstract description 5
- 235000012036 Vanilla tahitensis Nutrition 0.000 claims abstract description 5
- 240000008554 Aloysia triphylla Species 0.000 claims abstract description 4
- 235000013668 Aloysia triphylla Nutrition 0.000 claims abstract description 4
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims abstract description 4
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims abstract description 4
- 244000062730 Melissa officinalis Species 0.000 claims abstract description 4
- 235000010654 Melissa officinalis Nutrition 0.000 claims abstract description 4
- 240000007313 Tilia cordata Species 0.000 claims abstract description 4
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims abstract description 3
- 235000017309 Hypericum perforatum Nutrition 0.000 claims abstract description 3
- 235000003805 Musa ABB Group Nutrition 0.000 claims abstract description 3
- 240000008790 Musa x paradisiaca Species 0.000 claims abstract description 3
- 235000015266 Plantago major Nutrition 0.000 claims abstract description 3
- 235000006092 Stevia rebaudiana Nutrition 0.000 claims abstract description 3
- 239000001102 lavandula vera Substances 0.000 claims abstract description 3
- 235000018219 lavender Nutrition 0.000 claims abstract description 3
- 244000042664 Matricaria chamomilla Species 0.000 claims abstract 3
- 244000141009 Hypericum perforatum Species 0.000 claims abstract 2
- 238000002360 preparation method Methods 0.000 claims description 21
- 235000008216 herbs Nutrition 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 13
- 235000021028 berry Nutrition 0.000 claims description 10
- 239000012141 concentrate Substances 0.000 claims description 6
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 4
- 235000017803 cinnamon Nutrition 0.000 claims description 4
- 235000005911 diet Nutrition 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 238000001802 infusion Methods 0.000 claims description 4
- 244000263375 Vanilla tahitensis Species 0.000 claims description 3
- 235000019658 bitter taste Nutrition 0.000 claims description 3
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 3
- 244000178870 Lavandula angustifolia Species 0.000 claims description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 2
- 244000178231 Rosmarinus officinalis Species 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 230000000378 dietary effect Effects 0.000 claims description 2
- 235000002020 sage Nutrition 0.000 claims description 2
- 235000000346 sugar Nutrition 0.000 claims description 2
- -1 natural Substances 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 229930003935 flavonoid Natural products 0.000 abstract description 8
- 235000017173 flavonoids Nutrition 0.000 abstract description 8
- 150000002215 flavonoids Chemical class 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 4
- 244000290333 Vanilla fragrans Species 0.000 abstract description 3
- 239000003337 fertilizer Substances 0.000 abstract description 2
- 239000000575 pesticide Substances 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 244000165082 Lavanda vera Species 0.000 abstract 2
- 235000004357 Mentha x piperita Nutrition 0.000 abstract 2
- 241001184073 Basilicum Species 0.000 abstract 1
- 241000425932 Buddleja globosa Species 0.000 abstract 1
- 240000008394 Drimys winteri Species 0.000 abstract 1
- 235000008498 Drimys winteri Nutrition 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 235000010701 Lavanda vera Nutrition 0.000 abstract 1
- 244000246386 Mentha pulegium Species 0.000 abstract 1
- 235000016257 Mentha pulegium Nutrition 0.000 abstract 1
- 241001479543 Mentha x piperita Species 0.000 abstract 1
- 244000134552 Plantago ovata Species 0.000 abstract 1
- 235000003421 Plantago ovata Nutrition 0.000 abstract 1
- 244000181066 Rosa eglanteria Species 0.000 abstract 1
- 235000000542 Rosa eglanteria Nutrition 0.000 abstract 1
- 244000050054 Rosa moschata Species 0.000 abstract 1
- 235000015450 Tilia cordata Nutrition 0.000 abstract 1
- 235000003599 food sweetener Nutrition 0.000 abstract 1
- 235000001050 hortel pimenta Nutrition 0.000 abstract 1
- 239000001771 mentha piperita Substances 0.000 abstract 1
- 239000005445 natural material Substances 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
- 239000002349 well water Substances 0.000 abstract 1
- 235000020681 well water Nutrition 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 description 18
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 3
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 3
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 3
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 229930000044 secondary metabolite Natural products 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 2
- 239000005792 Geraniol Substances 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 2
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 2
- 241000847801 Simaba cedron Species 0.000 description 2
- 240000001717 Vaccinium macrocarpon Species 0.000 description 2
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 2
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229930014669 anthocyanidin Natural products 0.000 description 2
- 235000008758 anthocyanidins Nutrition 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000002921 anti-spasmodic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000037976 chronic inflammation Diseases 0.000 description 2
- 230000006020 chronic inflammation Effects 0.000 description 2
- WTEVQBCEXWBHNA-YFHOEESVSA-N citral B Natural products CC(C)=CCC\C(C)=C/C=O WTEVQBCEXWBHNA-YFHOEESVSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 235000004634 cranberry Nutrition 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 229940113087 geraniol Drugs 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- VIINAUVGZZLXGK-WPZRUTIUSA-N (2z)-3,7-dimethylocta-2,6-dien-1-ol;(2e)-3,7-dimethylocta-2,6-dien-1-ol Chemical compound CC(C)=CCC\C(C)=C/CO.CC(C)=CCC\C(C)=C\CO VIINAUVGZZLXGK-WPZRUTIUSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- OVSQVDMCBVZWGM-LQSBFMDOSA-N 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-LQSBFMDOSA-N 0.000 description 1
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N Caryophyllene epoxide Chemical compound C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 102000010907 Cyclooxygenase 2 Human genes 0.000 description 1
- 108010037462 Cyclooxygenase 2 Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 241000134874 Geraniales Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 235000003321 Ilex vomitoria Nutrition 0.000 description 1
- 241000209026 Ilex vomitoria Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 description 1
- 240000007591 Tilia tomentosa Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000019463 artificial additive Nutrition 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 230000002026 carminative effect Effects 0.000 description 1
- 229920006184 cellulose methylcellulose Polymers 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001906 cholesterol absorption Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 description 1
- 229960002626 clarithromycin Drugs 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000016396 cytokine production Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- FRMCCTDTYSRUBE-BGPZULBFSA-N spathulenol Chemical compound C1CC(=C)[C@@H]2CC[C@](C)(O)[C@H]2[C@@H]2C(C)(C)[C@@H]21 FRMCCTDTYSRUBE-BGPZULBFSA-N 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- KDSWDGKIENPKLB-QJDQKFITSA-N verbascoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC(=O)CCC=2C=C(O)C(O)=CC=2)[C@@H](CO)O[C@@H](OCCC=2C=C(O)C(O)=CC=2)[C@@H]1O KDSWDGKIENPKLB-QJDQKFITSA-N 0.000 description 1
- QFRYQWYZSQDFOS-UHFFFAOYSA-N verbascoside Natural products CC1OC(COC2C(O)C(COC3OC(C(O)C(O)C3O)C(=O)O)OC(Oc4cc(O)cc5OC(=CC(=O)c45)c6ccc(O)c(O)c6)C2O)C(O)C(O)C1O QFRYQWYZSQDFOS-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- VMYXUZSZMNBRCN-UHFFFAOYSA-N α-curcumene Chemical compound CC(C)=CCCC(C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
Definitions
- the present invention patent relates to a concentrated natural antioxidant liquid composition prepared only with components of herbs and shrubs produced under organic techniques, sweetened with stevia and prepared only with components of herbs and shrubs produced under organic techniques in a sachet presentation of 5 mL, in conditions to be used immediately, either with hot or cold water, to reconstitute a volume of 200 mL.
- Our invention postulated for patenting, has a concentrated natural antioxidant liquid composition ranging from 4662 to 16 ⁇ 7 ORAC, complying with 5 of the presented compositions, with the necessary daily full dose of antioxidants and the remaining 2 with good levels to be considered antioxidant drinks without No observation
- this antioxidant composition submitted to patenting is aimed at people with these pathologies or who wish to prevent them in addition to safeguarding health by preventing them from eating food with artificial colors and preservatives. In this way, it is intended to improve the health of consumers and their quality of life.
- Antioxidants reduce the effects of brain deterioration or aging.
- the combination of antioxidant and anti-inflammatory agents found in fruits and Vegetables can reduce or reverse the deficit of brain function and cognitive behaviors.
- a state of chronic inflammation is characterized by abnormal cytokine production and activation of inflammatory signaling pathways.
- Chronic inflammation plays a crucial role in the development of metabolic disorders associated with obesity, insulin resistance and atherosclerosis.
- Two important enzymes are involved in the inflammatory response: ⁇ NOS (nitric oxide synthetase) and COX-2 (cyclooxygenase 2).
- NOS and COX-2 can catalyze the synthesis of nitric oxide and prostagiandin E2, which can cause sepsis, a systemic inflammatory response syndrome. These enzymes can be inhibited with these products by reducing inflammation and related diseases.
- Polyphenols are able to inhibit the digestive enzymes alpha-glucosidae and alpha-amylase, whose role is to hydrolyze carbohydrates so that they are then absorbed in the intestine. This generates a delay in the digestion of carbohydrates and therefore a decreased absorption of post-prandial glycemia.
- Alpha-glucosidase is a key enzyme for metabolizing non-absorbing oligosaccharides into monosaccharides absorbable by the small intestine. Inhibition of this enzyme can delay the digestion of oligosaccharides and disaccharides to monosaccharides and decrease glucose absorption and reduce postprandial glycemia.
- alpha-glucosidase inhibitors The high concentration of alpha-glucosidase inhibitors is an attractive strategy to control hyperglycemia so that functional foods such as this could help patients with diabetes.
- Diabetes is associated with hyperglycemia and dyslipidemia, which cause oxidative stress and induce an inflammatory response that generates a large amount of free radicals causing cardiovascular complications.
- Antioxidant components prevent cholesterol absorption.
- Anthocyanidins and flavonoids protect against oxidation of LDL (low density lipoproteins) and prevent blood vessels from oxidative damage.
- a regular daily diet with antioxidants is positive for cardiovascular health.
- Cholesterol oxidation is a factor in the development of cardiovascular diseases including heart attack, atherosclerosis and ischemia.
- Proanthocyanidins help reduce the adhesion of certain strains of E. coli on the walls of the urinary tract.
- the main flavonoids of matico correspond to verbascoside, luteolin 7-O-glycoside, quercetin, apigenin 7-O-glycoside in addition to other secondary metabolites such as gallic acid all with antioxidant effects.
- the cedron, Aloysia triphylla has terpenes such as neral, geraniol nerol and geraniol, sesquiterpenoids ar-curcumene, bicycles, chisquifelandrene, spatulenol, nerolidol, 15-burbonne, isis-cariophilene and its oxide that showed a protective antioxidant effect in vitro , measured in a model lipid system (linoleic acid emulsion), at the same concentration, e.g. 10 g / L, equal to or greater than vitamin E and BHA.
- terpenes such as neral, geraniol nerol and geraniol, sesquiterpenoids ar-curcumene, bicycles, chisquifelandrene, spatulenol, nerolidol, 15-burbonne, isis-cariophilene and its oxide that showed a protective antioxidant effect in vitro , measured in a model
- Rosehip has a high proportion of vitamin C, a proportion that depending on the harvest time, can reach up to 513 mg / 100g in January and 844mg / 1 OOg in April
- Melissa has neral (30.4%) and geranial (39.0%) although considerable amounts of Caryophylene oxide (12.1%) were detected.
- the cinnamon is a tree used by millenary cultures of Chile for its multiple medicinal and ceremonial qualities, according to the MINSAL document, Chile, "traditional herbal medicines", occupied in the formulation to provide an antispasmodic effect in addition to giving the preparation a characteristic flavor
- vanilla is a food with high antioxidant power, it contains high ORAC levels in addition to a mild aroma and pleasant taste.
- the manufacturing process consists of two separate steps that are then joined to obtain by concentration in a rotary evaporator the final antioxidant composition.
- the first part consists in obtaining the concentrate of fresh, frozen or dried berries using water as a solvent by means of a rotary evaporator in order to preserve the greatest amount of vitamins, since when working under negative pressure it is possible that the water boils at a lower temperature avoiding The loss of these.
- the other part of the preparation consists of the infusion of herbs that is prepared with freshly boiled water that is poured over fresh or dried herbs in the established proportions and allowed to stand for no more than three minutes. After obtaining both, these are mixed and re-concentrated in the rotary evaporator until half of the original volume is obtained and immediately packed in sachet.
- Antioxidant compositions prepared with berries are disclosed in the state of the art as described in US2011244038 and WO200738421 with additional sugars, polysaccharides and polymers such as PVP, CMC, methylcellulose, chitosan, etc., all artificial additives unlike this new composition which starts from fruit without pesticides or chemical fertilizers to the preparation as such without preservatives or additives in order to make it healthier and increase the benefits in a food that by adding water gives the person all the flavonoids necessary to consume in the day.
- composition of the invention does not need to add preservatives and dyes, which are harmful to health, since it is packaged in a vacuum sachet and as it contains such high levels of antioxidants they act as preservatives and help preserve the preparation . Even effect on some bacteria has been observed comparing its effect in a study with clarithromycin.
- the dyes have been indicated as those responsible for allergic reactions and in children studies have been done in relation to the attention deficit, in addition to some carcinogens. This preparation has different colors, very attractive, coming from its components, all of natural origin.
- the antioxidant composition of the present invention also contains a large number of herbs that increase the contribution of different secondary metabolites belonging to each of these herbs and therefore increasing the amount of total antioxidants.
- composition of the invention contains the following components: matico 10-20% by weight, cedron 40-50%, mint 40-50%, linden 10-20%, lemon balm 20-50%, chamomile 5-10%, hypericum 5 -10%, lavender 0.5-1%, basil 10-30%, rosehip 30-40%, cranberry 30- 60%, plantain 5-10%, rosemary 10-20%, sage 10-20%, maqui 10-30%, cinnamon 1-5%, vanilla 2- 5% and spring water and Stevia rebaudiana 5 to 10%.
- the invention also contemplates the process for preparing said antioxidant composition.
- preparations a) and b) are mixed and concentrated again until reaching half the volume to obtain the final composition.
- the water used must be previously boiled to avoid the greatest amount of oxygen present in the water and thus avoid the oxidation of the herbs. Water is added between 90-100 ° C on dried or fresh medicinal herbs. The infusion is allowed to stand for only three minutes, if left longer the herbs oxidize and the organoleptic properties vary, the main disadvantage being the appearance of bitterness.
- the second part is to make the berry extract, it is prepared with blueberries, rosehip, maqui or others in a rotary evaporator to avoid the loss of vitamins using the lowest possible temperature to evaporate the water by means of the vacuum pressure for 20 minutes. Then they join both liquid parts and go through the rotary evaporator until they get half the volume of the mixture that was put in this step.
- the stevioside from stevia dissolves well from 50 ° C and is added at the end, in the concentrated mixture.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Compounds Of Unknown Constitution (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CL3402-2012 | 2012-12-03 | ||
CL2012003402A CL2012003402A1 (en) | 2012-12-03 | 2012-12-03 | Concentrated natural antioxidant liquid composition prepared only with components of herbs and shrubs produced under organic techniques, sweetened with stevia and the method of preparation of said composition. |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014085946A1 true WO2014085946A1 (en) | 2014-06-12 |
Family
ID=50882721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CL2013/000002 WO2014085946A1 (en) | 2012-12-03 | 2013-01-09 | Grass- and shrub-based natural antioxidant liquid composition and method for producing same |
Country Status (2)
Country | Link |
---|---|
CL (1) | CL2012003402A1 (en) |
WO (1) | WO2014085946A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016159767A2 (en) | 2015-03-30 | 2016-10-06 | Bio-Based Product Ontwikkelings Cooperatie U.A. (Boc) | Method for the preparation of a water-soluble extract of a vegetable biomass |
WO2020252461A1 (en) * | 2019-06-14 | 2020-12-17 | Codex Beauty Corporation | Natural skin care compositions and methods for treating oxidative stress and restoring skin health |
US11141374B2 (en) | 2019-06-14 | 2021-10-12 | Codex Beauty Corporation | Natural skin care compositions and methods for treating oxidative stress and restoring skin health |
US11141373B2 (en) | 2019-06-14 | 2021-10-12 | Codex Beauty Corporation | Natural skin care compositions and methods for treating oxidative stress and restoring skin health |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006063219A2 (en) * | 2004-12-09 | 2006-06-15 | Pro-Health, Inc. | Product and method for oral administration of nutraceuticals |
US20100062133A1 (en) * | 2008-08-25 | 2010-03-11 | Violeta Colova | Blended beverage composition of berry solids, yaupon solids and water |
EP2471383A1 (en) * | 2009-08-27 | 2012-07-04 | Ogawa & Co., Ltd. | Taste-improving agent for sweetener having high sweetness |
-
2012
- 2012-12-03 CL CL2012003402A patent/CL2012003402A1/en unknown
-
2013
- 2013-01-09 WO PCT/CL2013/000002 patent/WO2014085946A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006063219A2 (en) * | 2004-12-09 | 2006-06-15 | Pro-Health, Inc. | Product and method for oral administration of nutraceuticals |
US20100062133A1 (en) * | 2008-08-25 | 2010-03-11 | Violeta Colova | Blended beverage composition of berry solids, yaupon solids and water |
EP2471383A1 (en) * | 2009-08-27 | 2012-07-04 | Ogawa & Co., Ltd. | Taste-improving agent for sweetener having high sweetness |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016159767A2 (en) | 2015-03-30 | 2016-10-06 | Bio-Based Product Ontwikkelings Cooperatie U.A. (Boc) | Method for the preparation of a water-soluble extract of a vegetable biomass |
WO2020252461A1 (en) * | 2019-06-14 | 2020-12-17 | Codex Beauty Corporation | Natural skin care compositions and methods for treating oxidative stress and restoring skin health |
US11141374B2 (en) | 2019-06-14 | 2021-10-12 | Codex Beauty Corporation | Natural skin care compositions and methods for treating oxidative stress and restoring skin health |
US11141373B2 (en) | 2019-06-14 | 2021-10-12 | Codex Beauty Corporation | Natural skin care compositions and methods for treating oxidative stress and restoring skin health |
Also Published As
Publication number | Publication date |
---|---|
CL2012003402A1 (en) | 2013-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gruenwald | Novel botanical ingredients for beverages | |
Ali et al. | 26 Nutritional and medicinal | |
US20050175720A1 (en) | Vaccinium species compositions with novel beneficial properties | |
Rabeta et al. | Effect of different drying methods on the antioxidant properties of Vitex negundo Linn. tea. | |
Arshad et al. | Replacement of refined sugar by natural sweeteners: Focus on potential health benefits | |
WO2014085946A1 (en) | Grass- and shrub-based natural antioxidant liquid composition and method for producing same | |
JP2011500078A (en) | Functional beverage | |
Patel | Emerging bioresources with nutraceutical and pharmaceutical prospects | |
Yadav et al. | Effect of storage time on Aloe vera beverage | |
Iqbal et al. | Synergic interactions between berry polyphenols and gut microbiota in cardiovascular diseases | |
Mortaş et al. | Nutritional evaluation of commonly consumed berries: composition and health effects | |
US8895083B2 (en) | Composition for the maintenance of blood sugar levels comprising cinnamon and ginseng | |
WO2016178091A1 (en) | Frozen tea treat with non-synthetic ingredients and method of making the same | |
KR101444875B1 (en) | Beverage composition comprising hibiscus extract and l-carnitine with improved sensory property and stability | |
RU2532927C2 (en) | Alcohol-free beverage | |
Fazil et al. | Why the “sugars” in traditional Unani formulations are a pivotal component: A viewpoint perspective | |
Rakha et al. | Scrabbling the Nutraceutical Potential of Berries in Gastrointestinal Disorders: A Review | |
Manful et al. | Berries | |
Lim | Opuntia ficus-indica | |
CN104435356B (en) | The herbal composite of anti-chicken heat shock | |
KR20160018963A (en) | Beverage and Method thereof making beverage using elderberry | |
KR101646516B1 (en) | Food composition comprising extract of nelumbo nucifera leaf, seed, and olive leaf | |
Feresin et al. | Tree Berries | |
ES2697049T3 (en) | Compositions based on plants and uses | |
US20150320076A1 (en) | CANDY AND OTHER CARRIERS FORTIFIED WITH TEA POLYPHENOLS or GRAPE SEEDS EXTRACT |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13860953 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13860953 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 11/12/2015) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13860953 Country of ref document: EP Kind code of ref document: A1 |